|
ZNHIT3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.13989999661612E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.42240000000626E-06 |
| Normal-vs-Stage2 |
1.171990E-02 |
| Normal-vs-Stage3 |
2.614400E-02 |
| Normal-vs-Stage4 |
1.573610E-02 |
| Stage1-vs-Stage2 |
7.328000E-01 |
| Stage1-vs-Stage3 |
4.536400E-01 |
| Stage1-vs-Stage4 |
2.630800E-01 |
| Stage2-vs-Stage3 |
7.539000E-01 |
| Stage2-vs-Stage4 |
1.767420E-01 |
| Stage3-vs-Stage4 |
1.200790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.02180000016716E-08 |
| Normal-vs-AfricanAmerican |
8.235200E-04 |
| Normal-vs-Asian |
7.169800E-02 |
| Caucasian-vs-AfricanAmerican |
9.350600E-01 |
| Caucasian-vs-Asian |
4.254200E-01 |
| AfricanAmerican-vs-Asian |
5.496200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.2058999949468E-08 |
| Normal-vs-Female |
1.32949999998022E-06 |
| Male-vs-Female |
9.478200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.382000E-03 |
| Normal-vs-Extreme_Weight |
2.38990000001049E-06 |
| Normal-vs-Obese |
5.65839999999707E-05 |
| Normal-vs-Extreme_Obese |
9.382300E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.915400E-01 |
| Normal_Weight-vs-Obese |
8.830600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.279800E-01 |
| Extreme_Weight-vs-Obese |
6.420400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.324400E-01 |
| Obese-vs-Extreme_Obese |
9.872000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.621000E-04 |
| Normal-vs-Age(41-60Yrs) |
4.28119983908459E-10 |
| Normal-vs-Age(61-80Yrs) |
7.71500000000813E-05 |
| Normal-vs-Age(81-100Yrs) |
5.936000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.532430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.874000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.372310E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.368300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.710300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.570600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.16150422613259E-11 |
| Normal-VS-Type2 PRCC |
3.154400E-02 |
| Normal-VS-KIRP CIMP |
6.423900E-02 |
| Normal-VS-Unclassified PRCC |
7.955800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.436270E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.653200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.308200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.107400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.736800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.842000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.015700E-03 |
| Normal-vs-N1 |
6.037000E-03 |
| Normal-vs-N2 |
7.928000E-01 |
| N0-vs-N1 |
4.503600E-01 |
| N0-vs-N2 |
3.748600E-01 |
| N1-vs-N2 |
2.749200E-01 |
|
|
